TY - JOUR
T1 - Whole-cell biocatalysis
T2 - Evaluation of new hydrophobic ionic liquids for efficient asymmetric reduction of prochiral ketones
AU - Bräutigam, Stefan
AU - Dennewald, Danielle
AU - Schürmann, Melanie
AU - Lutje-Spelberg, Jeffrey
AU - Pitner, William Robert
AU - Weuster-Botz, Dirk
PY - 2009/10/7
Y1 - 2009/10/7
N2 - A biphasic process design is often applied in whole-cell biocatalysis if substrate and product have low water solubility, are unstable in water or toxic for the biocatalyst. Some water immiscible ionic liquids (ILs) with adequate distribution coefficients have already been applied successfully as second liquid phase, which acts as a substrate reservoir and in situ extractant for the product. In this work, 12 new ILs were evaluated with respect to their applicability in biphasic asymmetric reductions of prochiral ketones in comparison to 9 already published ILs. The ILs under study are composed of seven different cations and three different anions. Recombinant Escherichia coli was used as whole-cell biocatalyst overexpressing the genes of a Lactobacillus brevis alcohol dehydrogenase (LB-ADH) and a Candida boidinii formate dehydrogenase (CB-FDH) for cofactor regeneration. Best results were achieved if ionic liquids with [PF6]- and [NTF]-anions were applied, whereas [FAP]-ILs showed minor qualification, e.g., the use of [HMPL][NTF] as second liquid phase for asymmetric synthesis of (R)-2-octanol resulted in a space-time-yield of 180 g L-1 d-1, a chemical yield of 95% and an enantiomeric excess of 99.7% in a simple batch process.
AB - A biphasic process design is often applied in whole-cell biocatalysis if substrate and product have low water solubility, are unstable in water or toxic for the biocatalyst. Some water immiscible ionic liquids (ILs) with adequate distribution coefficients have already been applied successfully as second liquid phase, which acts as a substrate reservoir and in situ extractant for the product. In this work, 12 new ILs were evaluated with respect to their applicability in biphasic asymmetric reductions of prochiral ketones in comparison to 9 already published ILs. The ILs under study are composed of seven different cations and three different anions. Recombinant Escherichia coli was used as whole-cell biocatalyst overexpressing the genes of a Lactobacillus brevis alcohol dehydrogenase (LB-ADH) and a Candida boidinii formate dehydrogenase (CB-FDH) for cofactor regeneration. Best results were achieved if ionic liquids with [PF6]- and [NTF]-anions were applied, whereas [FAP]-ILs showed minor qualification, e.g., the use of [HMPL][NTF] as second liquid phase for asymmetric synthesis of (R)-2-octanol resulted in a space-time-yield of 180 g L-1 d-1, a chemical yield of 95% and an enantiomeric excess of 99.7% in a simple batch process.
KW - (R)-2-octanol
KW - Asymmetric reduction
KW - Biocatalysis
KW - Cofactor regeneration
KW - Ionic liquid
KW - Recombinant E. coli
UR - http://www.scopus.com/inward/record.url?scp=68349155683&partnerID=8YFLogxK
U2 - 10.1016/j.enzmictec.2009.06.015
DO - 10.1016/j.enzmictec.2009.06.015
M3 - Article
AN - SCOPUS:68349155683
SN - 0141-0229
VL - 45
SP - 310
EP - 316
JO - Enzyme and Microbial Technology
JF - Enzyme and Microbial Technology
IS - 4
ER -